The mechanisms through which estrogen regulates gonadotropin-releasing hormone (GnRH) neurons to control mammalian ovulation are unknown. We found that estrogen positive feedback to generate the preovulatory gonadotropin surge was normal in estrogen receptor b knockout (ERb) mutant mice, but absent in ERa mutant mice. An ERa-selective compound was sufficient to generate positive feedback in wild-type mice. As GnRH neurons do not express ERa, estrogen positive feedback upon GnRH neurons must be indirect in nature. To establish the cell type responsible, we generated a neuron-specific ERa mutant mouse line. These mice failed to exhibit estrogen positive feedback, demonstrating that neurons expressing ERa are critical. We then used a GnRH neuron-specific Pseudorabies virus (PRV) tracing approach to show that the ERa-expressing neurons innervating GnRH neurons are located within rostral periventricular regions of the hypothalamus. These studies demonstrate that ovulation is driven by estrogen actions upon ERaexpressing neuronal afferents to GnRH neurons.
Introduction
The gonadotropin-releasing hormone (GnRH) neurons represent the key output cells of the neuronal network controlling fertility in all mammalian species. The GnRH neurons and associated cells that comprise the ''GnRH neuronal network'' are responsible for integrating multiple internal homeostatic and external environmental signals to ensure appropriate levels of fertility for the individual (Levine, 1997; Herbison, 2006) . Arguably, the most important of these signals is that of estrogen, secreted by the gonads to achieve feedback regulation of gonadotropin secretion (Herbison, 1998; Petersen et al., 2003) . Throughout most of the menstrual cycle, estrogen suppresses gonadotropin secretion, but at mid-cycle, switches to have a potent stimulatory or ''positive feedback'' action to evoke the luteinizing hormone (LH) surge that triggers ovulation. Although feedback effects of estrogen are known to occur at the pituitary gland (Shupnik, 1996) , actions of estrogen within the brain are accepted as being critical for the generation of the GnRH surge that drives the preovulatory LH surge in all mammals, including primates Herbison, 1998) .
Even though estrogen positive feedback is central to mammalian fertility, the underlying mechanism remains poorly understood. Since GnRH neurons express ERb, but not ERa, it is possible that estrogen acts directly upon them to generate the GnRH surge (Herbison and Pape, 2001; Petersen et al., 2003) . However, several lines of evidence indicate that effects of estrogens may be transmitted to GnRH neurons in an indirect manner by ERa-and/or ERb-expressing neurons, glia, or endothelial cells (Rage et al., 1997; Smith and Jennes, 2001; Prevot, 2002; Petersen et al., 2003) . The detailed investigation of this mechanism has been hampered by the scattered distribution of the GnRH neurons, which makes them difficult to investigate technically. Thus, at present, neither the estrogen receptor subtype (ERa versus ERb), nor the critical cell types involved in estrogen positive feedback, have been defined, and much controversy surrounds this critical issue. A genetic approach to define which of these two estradiol receptors is crucial for GnRH neuronal activation to induce ovulation, and to characterize its role in specific cells, might provide valuable insights. Using mice in which ERa or ERb has been inactivated, we firstly demonstrate here that ERa, but not ERb, is required for estrogen positive feedback to GnRH neurons. Using an ERa-selective ligand in wild-type mice, we show that ERa is not only necessary, but also sufficient to generate estrogen positive feedback. Secondly, by exploiting a neuron-specific mutation of the ERa gene, we were able to identify neurons, as opposed to other cell types, as critical targets for estradiol action. This clearly establishes that neurons expressing ERa are required for estrogen to activate GnRH neurons. Finally, through use of a GnRH neuron-specific Pseudorabies virus (PRV) tracing approach, we have been able to define the location of ERa-expressing neurons projecting to GnRH neurons. These data demonstrate a key role for ERa in mammalian estrogen positive feedback and provide definitive evidence for the ''indirect model'' of estrogen action, in which estrogen regulates ERaexpressing neuronal afferents to the GnRH neurons to bring about the preovulatory GnRH/LH surge.
Results

Estrogen Positive Feedback Affecting LH Secretion and GnRH Neuron Activation Is Absent in ERa Mutant, but Normal in ERb Mutant, Female Mice
The stimulatory effects of estrogen positive feedback were evaluated using a protocol that enabled the activation status of GnRH neurons to be assessed alongside changes in plasma LH levels. Ovariectomized wild-type C57BL6/J mice, given an estradiol capsule followed by an injection of estradiol benzoate, were found to exhibit an LH surge centered around 19:00 hr, on lights out (Figure 1A) . In the ERa mutant mice, there was no evidence of an LH surge in any of the mice (n = 8) in response to the same estrogen regimen, with mean LH levels at 19:00 hr of 1.6 6 0.3 ng/ml compared with 5.2 6 1.0 ng/ml in wild-type control animals (n = 7, p < 0.05; Figure 1B ). In contrast, clear evidence of an LH surge was observed in each of the ovariectomized, estrogen-treated ERb mutant mice (mean LH levels of 8.6 6 1.7 ng/ml compared with 8.9 6 1.5 ng/ml in controls, n = 7 for each group) (Figure 2A ).
Approximately 40% of the GnRH neuronal population expresses the immediate early gene c-Fos at the time of the GnRH surge, and this is believed to be an accurate indicator of those GnRH neurons activated by estrogen to generate the GnRH surge (Hoffman et al., 1993) . In addition, there is increasing evidence that neurons within the anteroventral periventricular nucleus (AVPV) of the rostral hypothalamus may be an important target for estrogen in bringing about the GnRH surge (Herbison, 1998; Simerly, 2002) . Dual-label immunocytochemistry (Figures 1C and 1D) revealed that approximately 40% of GnRH neurons in wild-type mice expressed c-Fos at the time of the estrogen-induced LH surge ( Figures 1C  and 1E ). The GnRH neurons expressing c-Fos were located preferentially within the preoptic area, with duallabeled GnRH neurons only rarely detected in more rostral areas, such as the medial septum (data not shown). In contrast, we detected no GnRH neurons that expressed c-Fos in any brain region of ERa mutant mice ( Figures 1D and 1E) . The distribution and number of GnRH neurons detected in wild-type and ERa mutant females were not different (data not shown). In addition, we found that the numbers of singly-labeled, c-Fos-expressing cells located within the AVPV were significantly greater in wild-type mice ( Figure 1F ) compared with ERa mutant females (p < 0.05; Figures 1G and 1H) .
Single-and dual-label immunocytochemistry experiments in ERb mutant females revealed no differences in the number of dual-labeled c-Fos-GnRH neurons compared with wild-type controls ( Figure 2B ) or in the number of c-Fos-expressing cells detected in the AVPV ( Figure 2C ). The distribution and number of GnRH neurons in wild-type and ERb mutant females were also not different (data not shown).
An ERa-Specific Ligand Is Sufficient to Generate Positive Feedback in Wild-Type Mice The results with the ERa and ERb mutant mice indicated that ERa was necessary for estrogen positive feedback. To evaluate whether ERa pathways were sufficient for positive feedback, wild-type mice were given the ERaselective compound 16a-LE2 [3,17-dihydroxy-19-nor17a-pregna-1,3,5 (10)-triene-21,16a-lactone] (HegeleHartung et al., 2004) as the second estradiol injection alongside control mice receiving the normal, previously outlined estrogen protocol. The second estradiol injection is critical for evoking positive feedback, as mice given vehicle control at this time point never exhibit an LH surge. Mice treated with 16a-LE2 (n = 5) exhibited an LH surge at 19:00 hr (LH, 5.9 6 1.7 ng/ml, compared with normal estrogen-treated controls, 6.5 6 2.3 ng/ml) and had 49% 6 7% of rostral preoptic area GnRH neurons expressing c-Fos (compared with controls that had 60% 6 11%).
Together, these observations demonstrate that cells expressing ERa are both necessary and sufficient for estrogen positive feedback actions upon GnRH neurons. As GnRH neurons do not express ERa, these results demonstrate that ERa-expressing neuronal, glial, or other cell types must mediate estrogen positive feedback actions upon GnRH neurons.
Neuron-Specific ERa Mutant Mice Are Infertile
To examine the hypothesis that estrogen acts through ERa-expressing neurons, rather than other cell types, to activate GnRH neurons, neuron-specific ERa mutant mice were developed by breeding ERaflox mice with a CamKIIa-Cre transgenic mouse line. Immunocytochemical analyses of ERa expression in the resulting mice showed that ERa immunoreactivity was absent from the hypothalamus ( Figures 3A and 3B ) and all other brain regions (see Figure S2 ;CamKIIa-Cre mice (Figures 3A and 3B, insets) . Female ERa fl/fl ;CamKIIa-Cre mice were found to be infertile and, from an age of 5 to 6 weeks, to exhibit striking abnormalities in their reproductive organs (Figure 4) . In the mutants, the uterus was grossly enlarged and filled with liquid ( Figure 4B ). The endometrium, however, was severely atrophic and lacked all glandular structures. Whereas the endometrial stroma was loose and vascularized in control mice ( Figure 4C ), it appeared condensed and showed granulocyte infiltration in the mutants ( Figure 4D ). Histologically, the ovaries of ERa fl/fl ;CamKIIa-Cre mice showed signs of gonadotropin hyperactivation; in mutant mice, ovaries contained a large number of antral follicles compared with wildtype animals ( Figures 4E and 4F ). In the ovarian hilus, theca cells appeared hypertrophic and luteinized in mutant animals, indicating inappropriate stimulation of the ovaries. Furthermore, no corpora lutea were observed in the ovaries of mutants ( Figure 4F ), suggesting a failure of ovulation. Basal LH levels were not different between diestrous controls (0.91 6 0.11 ng/ml) and ERa fl/fl ;CamKIIa-Cre (1.23 6 0.08 ng/ml) female mice. ;CamKIIa-Cre mice (n = 6) failed to exhibit an LH surge, with mean LH levels of 0.9 6 0.2 ng/ml at 19:00 hr compared with 5.8 6 2.1 ng/ml in littermate controls (n = 5; Figure 3C ). Immunocytochemical experiments did not detect c-Fos in any GnRH neurons in ERa fl/fl ;CamKIIa-Cre mice following estrogen treatment. This compared with c-Fos in 41% 6 8% of GnRH neurons in littermate controls ( Figure 3D ).
As c-Fos protein is detectable for 5-6 hr in GnRH neurons following the GnRH/LH surge (Lee et al., 1990) , we additionally evaluated c-Fos expression in GnRH neurons at midday of the expected day of the surge and at 01:00 hr (1 a.m.) on the following day to evaluate whether the timing of positive feedback had been altered in ERa fl/fl ;CamKIIa-Cre mice. We found a complete absence of c-Fos in GnRH neurons at these time points. ;CamKIIa-Cre mice (p < 0.05; Figure 3E) . These data closely resemble that of the global ERa mutant mouse and indicate that ERa-expressing neurons are critical for estrogen positive feedback to occur.
The ERa-Expressing Primary Afferents to GnRH Neurons Are Located within Periventricular Regions of the Rostral Hypothalamus
The studies above show that ERa-expressing neurons are critical for estrogen positive feedback to GnRH neurons. To identify the locations of these cells within the GnRH neuronal network, we have used a Cre-dependent PRV retrograde tracing strategy in GnRH-Cre mice (DeFalco et al., 2001; Yoon et al., 2005) . In this approach, the Ba2001 PRV is activated only after infecting a Creexpressing GnRH neuron in vivo. This allows for the now unconditional PRV to replicate and to pass in a retrograde manner to the primary afferents of the GnRH neuron and, subsequently, their own afferents in a timedependent manner. The retrograde chain of infection can be followed by evaluating GFP expression as the unconditional Ba2001 PRV also expresses GFP in each cell it infects.
Five founder GnRH-Cre lines were generated. Analysis of Cre expression by dual-label immunocytochemistry in adult female mice revealed that one of these lines expressed Cre in a highly selective manner within 97% 6 2% of all GnRH neurons (n = 6; Figure 5A ). Crossing this line with the ROSA-26 indicator mice (Soriano, 1999) revealed Cre-dependent recombination in 97% 6 1% of GnRH neurons (n = 4; not shown).
To evaluate the ERa-expressing afferents to the GnRH neuron population that is activated at the time of the GnRH surge (i.e., those in the rostral preoptic area), a single 500 nl injection of Ba2001 PRV was given into the rostral preoptic area of adult female mice. Mice examined at 6, 12, 24, and 30 hr after injection of Ba2001 (n = 8) displayed no evidence of GFP expression in any region of the brain. However, 48 hr after PRV injection (n = 4), we found that between five and nine GnRH neurons located around the injection site expressed GFP (Figures 5B and 5C) indicating that Cre-mediated recombination had occurred in these cells. No other GFP-expressing cells were detected within the brain at this time point. Seventy-two hours following PRV injection, GFP-expressing cells (representing afferent neurons to rostral preoptic GnRH neurons, Figure 5D ) were identified in multiple brain regions. Twenty-four hours later (96 hr post-injection), we found a much larger distribution and number of GFP-expressing cells. As 24 hr is required for PRV to move from one order of neurons to the next (Card and Enquist, 1995; Horvath et al., 2002) , the neurons identified at 72 hr post-injection are almost certainly primary afferents to GnRH neurons.
At 72 hr post-injection (n = 6), GFP-expressing neurons were identified in multiple areas of the forebrain and brainstem ( Figure 5G ). The regions displaying the largest numbers of retrogradely labeled neurons were the hypothalamic periventricular nucleus (PeN; mean of 36 cells/ mouse in a 1:3 series of brain sections), AVPV (23 cells), median preoptic nucleus (MnPO; 14 cells), and dorsal raphe (16 cells). Other brain regions that consistently exhibited GFP-expressing neurons at lower densities were the lateral septum, arcuate nucleus (ARN), and nucleus tractus solitarius ( Figure 5G ). ;CamKIIa-Cre (F) mice shows increased numbers of antral follicles and lack of corpora lutea in the mutant.
Neuron
Dual-label immunocytochemistry (n = 6) for GFP and ERa ( Figures 5D and 5E ) identified ERa-expressing afferents as being located in four brain regions: the AVPV, MnPO, PeN, and ARN ( Figure 5F ). The percentage of GFP-positive neurons expressing ERa was 53% 6 12%, 34% 6 21%, and 24% 6 11% in the AVPV, MnPO, and PeN, respectively, and 56% 6 19% for the ARN, although we only ever observed 1-2 GFPexpressing cells in the ARN ( Figure 5G ). To ensure the neuronal identity of PRV-infected cells expressing ERa, immunocytochemical labeling for GFP and ERa was undertaken in combination with Nissl staining. All GFP/ERa-expressing cells were also positive for Nissl ( Figure S3 ). Injections of Ba2001 PRV into the rostral preoptic area of wild-type, non-Cre-expressing mice, or into the striatum of GnRH-Cre mice, resulted in a complete absence of GFP-expressing neurons. These findings demonstrate that ERa-expressing primary afferents to GnRH neurons have their cell bodies located principally within rostral periventricular nuclei of the hypothalamus.
The findings of the PRV study demonstrated that significant estrogen-receptive primary afferents to the GnRH neurons existed in the PeN and MnPO in addition to the AVPV. As such, we returned to the estrogen positive feedback c-Fos studies and examined c-Fos expression in the MnPO and PeN of ERa and ERb mutant mice. The numbers of c-Fos cells in the PeN of mice treated with estrogen were significantly reduced in ERa mutants (22 6 3 cells, p < 0.05) compared with wild-type mice (40 6 6 cells per section), but were unchanged in ERb mutant females. The numbers of c-Fos-expressing cells in the MnPO were not significantly different in either ERa or ERb mutant mice compared with controls. These data indicate that a subpopulation of cells within the PeN, as well as the AVPV, is activated by estrogen positive feedback.
Discussion
We have used here a series of ER mutant mouse models and an ER-selective ligand to demonstrate the critical receptor isoform and cell type necessary and sufficient for estrogen to initiate the GnRH/LH surge and ovulation. We show that global ERb mutant mice exhibit normal patterns of estrogen-induced GnRH activation and LH surge secretion. In contrast, global ERa mutant mice fail to exhibit GnRH neuron activation or LH surge secretion in response to estrogen. As GnRH neurons do not express ERa (Herbison and Pape, 2001) , this indicated that positive feedback effects of estrogen must occur in an indirect manner. To define the critical ERa-expressing cell-type in the pathway, neuronspecific ERa mutant mice were generated by crossing a floxed exon 3 ERa mouse line with CamKIIa-Cre mice. CamKIIa is expressed selectively by forebrain neurons (Ouimet et al., 1984; Burgin et al., 1990 ) and the CamKIIa-Cre mouse line used here has been shown previously to efficiently delete loxP-flanked target sequences in neurons of the CNS, leading to neuronspecific gene ablation (Casanova et al., 2001; Marsicano et al., 2003) . Mice harboring a neuron-specific ERa deletion were found to be infertile and lack estrogen positive feedback, demonstrating that ERa-expressing neurons are critical. To define the location of these neurons, we have used a Cre-dependent PRV retrograde tracing strategy to demonstrate that the ERa-expressing primary afferents to GnRH neurons are located primarily within the periventricular nuclei of the rostral hypothalamus. Together, these observations provide conclusive evidence that critical positive feedback actions of estrogen upon GnRH neurons are mediated by ERaexpressing neuronal afferents within the GnRH neuronal network.
It is now recognized that estrogen can modulate the activity of neuronal networks through multiple mechanisms including both slow genomic and rapid actions (McEwen and Alves, 1999) . In the case of estrogen positive feedback, however, it seems clear that classical genomic mechanisms underlie the estrogen activation of GnRH neurons. In all species examined, positive feedback only occurs after several hours of estrogen exposure (Legan et al., 1975; Bronson, 1981; Xia et al., 1992; Evans et al., 1997) . Furthermore, once the animal has been exposed to estrogen for a sufficient period, estrogen can be removed without having any negative effect upon subsequent GnRH neuron activation. Thus, rapid and immediate actions of estrogen are not likely to be critical for GnRH neuron activation, and positive feedback relies upon a classical genomic mechanism. The downstream genes regulated by estrogen to bring about GnRH neuron activation are not yet established, although the progesterone receptor is one candidate known to be potently regulated by estrogen (Levine, 1997; Shughrue et al., 1997) . The finding of ERb mRNA and protein in GnRH neurons of the mouse (Skynner et al., 1999a) , the rat (Hrabovszky et al., 2001) , and more recently, the sheep (Skinner and Dufourny, 2005) raised the possibility that estrogen might act directly upon GnRH neurons via this isoform to generate the GnRH/LH surge (Herbison and Pape, 2001 ). However, in terms of both LH secretion and immediate early gene expression in GnRH neurons, we found that estrogen positive feedback is normal in the global ERb mutant mouse. This strongly suggests that ERbregulated signaling within GnRH neurons is not critical for estrogen's positive feedback effects upon these cells.
The global ERa mutant mice are infertile and exhibit an anovulatory ovarian phenotype with polycystic follicles and an absence of corpora lutea . We provide evidence here that the failure of estrogen positive feedback on the GnRH neuronal network is very likely to underlie the anovulatory phenotype of the global ERa mutant mice. Estrogen administration to ovariectomized global ERa mutant mice failed to generate an LH surge or evidence of GnRH neuron activation. This provided direct evidence of the critical importance of ERa-expressing cells in positive feedback. In keeping with this observation, the ERa-selective compound 16a-LE2 (Hegele-Hartung et al., 2004 ) was found to be capable of eliciting normal positive feedback in wild-type mice. This indicates that ERa activation is both necessary and sufficient for positive feedback to occur, and that estrogen acts indirectly to activate GnRH neurons. Several different modes of indirect estrogen input to the GnRH neurons have been proposed and include effects mediated by vascular endothelial cells, tanycytes, glial cells, and interneurons (Rage et al., 1997; Herbison, 1998; Smith and Jennes, 2001; Prevot, 2002; Petersen et al., 2003) . Using a CreLoxP conditional mutagenesis strategy to generate a neuron-specific ERa knockout, we have been able to demonstrate that, of these possibilities, it is ERa-expressing neurons within the network that are critical for estrogen positive feedback. Other cell types expressing ERa may play a role in positive feedback, but are insufficient by themselves to activate the GnRH neurons to generate the GnRH/LH surge. Thus, the present genetic dissection of the estrogen positive feedback mechanism identifies clearly both the critical ER isoform and cell type involved.
The absence of estrogen positive feedback in neuronspecific ERa mutant mice is entirely compatible with their infertile reproductive phenotype. Ovarian histology shows an absence of corpora lutea and an abundance of antral follicles, supporting the failure of the ovulatory mechanism. In contrast to the global ERa mutant line, there was no evidence in neuron-specific ERa mutant mice for a polycystic hemorrhagic ovarian phenotype generated by excessive gonadotrophin secretion . Indeed, basal LH levels are not elevated in neuron-specific ERa mutant mice, suggesting that pituitary estrogen negative feedback is probably sufficient to restrain gonadotrophin secretion. Another prominent feature of the neuron-specific ERa mutant mice is that of dilated, fluid-filled uteri, reminiscent of those found at proestrus. Unlike in the global ERa mutant mouse Dupont et al., 2000) , the uteri of neuron-specific ERa mutant mice remain sensitive to estrogen and may be exposed to a continual high level of estrogen originating from the large numbers of developing follicles. Thus, the reproductive phenotype of the neuron-specific ERa mutant mouse is compatible with that of a mouse in which estrogen negative feedback is competent, but positive feedback is absent. This would enable relatively normal basal gonadotrophin secretion, sufficient to promote follicular growth and estrogen production, to exist in association with a complete failure of ovulation.
Studies in the rat have implicated the AVPV as an estrogen-sensitive brain region involved in the positive feedback mechanism (Wiegand and Terasawa, 1982; Herbison, 1998; Simerly, 2002) . The present results provide definitive evidence for this hypothesis and also suggest that the locations of estrogen-sensitive neurons involved in estrogen positive feedback include the preoptic PeN immediately caudal to the AVPV. To determine the locations of ERa-expressing afferents to GnRH neurons, we generated a GnRH-Cre transgenic mouse for use with a Cre-dependent PRV retrograde tracing strategy (DeFalco et al., 2001) . By establishing a time course of viral infection and restricting our PRV injection sites to the rostral preoptic area, where GnRH neurons expressing c-Fos at the time of positive feedback reside, we traced out the primary afferents to the subpopulation of GnRH neurons activated by estrogen to create the preovulatory GnRH surge. Primary afferent inputs to GnRH neurons were found to originate from a variety of predominantly midline hypothalamic and brainstem locations. However, the subpopulations of ERa-expressing afferents were found to be tightly clustered within the rostral preoptic area. In addition to a strong projection from ERa-expressing neurons in the AVPV, we also identified populations of ERa primary afferents originating from the PeN and, nearby the GnRH somata, in the MnPO. Our c-Fos studies support the functional relevance of both AVPV and PeN neurons in estrogen positive feedback, since a strong correlation existed between levels of c-Fos in these brain regions and GnRH neuron activation and the occurrence of an LH surge. A similar observation has been made in the rat, where c-Fos is expressed by AVPV/PeN neurons in response to estrogen positive feedback (Le et al., 1999) .
Brought together, the evidence for the AVPV and PeN as sites of primary afferents mediating estrogen positive feedback to rodent GnRH neurons is now very strong; (1) lesions of the AVPV/ventral PeN abolish positive feedback (Wiegand and Terasawa, 1982) , (2) implantation of anti-estrogens in the AVPV/PeN abolish positive feedback (Petersen and Barraclough, 1989) , (3) AVPV and PeN neurons provide inputs to GnRH neurons (present study; Horvath et al., 1993; Gu and Simerly, 1997; Simonian et al., 1999) , (4) neurons expressing ERa are critical for estrogen positive feedback (present study), (5) AVPV and PeN neurons express ERa and are activated by estrogen positive feedback (present study; Le et al., 1999) , and (6) AVPV/PeN neurons expressing ERa project directly to GnRH neurons (present study).
Together, these studies clarify the mechanism of estrogen positive feedback to GnRH neurons by providing definitive evidence that it is ERa, and not ERb, that is critical and that the neuron-specific ablation of ERa renders mice infertile with a complete ablation of estrogen positive feedback. Thus, estrogen acts indirectly upon GnRH neurons to bring about positive feedback driving ovulation, and the ERa-expressing neurons mediating this pathway are located in periventricular regions. Future studies involving the genetic ablation of ERa in specific neuronal phenotypes will now be required to define the hierarchy of periventricular neurons mediating estrogen feedback to GnRH neurons.
Experimental Procedures
Generation of an ERaflox Mouse Line A conditional allele of the mouse Esr1 allele was generated. The targeting construct (pERaflox.tkneo.DTA) ( Figure S1A , top panel) was based on a 9 kb BamHI fragment representing the genomic sequence of exon 3 and surrounding introns of the mouse Esr1 gene ( Figure S1A, second panel) . This fragment, obtained from the RPCI21 mouse genomic library (Vente et al., 1999) , was modified using homologous recombination in E. Coli (Zhang et al., 1998) to carry a loxP site 5 0 to exon 3, a PGKtkneo cassette flanked by frt sites, and one loxP site in the 3 0 direction of exon 3. E14 embryonic stem cells were transfected with the linearized targeting construct and selected for construct integration (Tronche et al., 1999) . G418-resistant clones were characterized by Southern blot using external genomic probes from the Estra locus ( Figure S1B ). Clones that had undergone homologous recombination were transiently transfected with the expression plasmid pCAGGS-Flpe (Schaft et al., 2001) and selected with 1 mM Gancyclovir to isolate subclones that have lost the selection cassette after Flp recombination. This was verified by Southern blot analysis ( Figure S1C ). From the resulting embryonic stem cell clones, chimeric mice were generated by blastocyst injection and uterine transfer. By breeding these chimeras to C57BL/6 mice, the ERaflox mouse line was established.
To generate a neuron-specific ERa knockout mouse, ERaflox mice were bred to CamKIIa-iCre BAC transgenic mice (referred to as CamKIIa-Cre mice) (Casanova et al., 2001) . CamKIIa is expressed around birth in almost all forebrain neurons but not in glial cells (Ouimet et al., 1984; Burgin et al., 1990) . This resulted in the generation of ERa 
Generation of a GnRH-Cre Transgenic Mouse
The GnRH-Cre mouse was generated in the same manner as reported previously (Skynner et al., 1999b) using an w12 kb transgene incorporating all the introns and exons of the GnRH gene, 5.5 kb of upstream (5 0 ) and 3.5 kb of downstream (3 0 ) flanking sequence, and a SmaI site engineered by site-directed mutagenesis in exon II between sequences encoding amino acids 2 and 3 of the GnRH decapeptide. An expression cassette consisting of (in 5 0 to 3 0 order) a synthetic intron, nuclear-localizing signal, CRE recombinase, and a polyadenylation (polyA) sequence was then inserted at the SmaI site to produce the transgene. Transgenic mice were produced by pronuclear injection and identified by PCR analysis of genomic DNA isolated from tail biopsies.
Animals and Estradiol-Induced LH Surge Protocol
All animal experimental procedures were approved by the University of Otago Animal Ethics Committee and the Regierungsprä sidium Karlsruhe. Animals were housed in groups of three to four per cage with food and water freely available and a 12:12 lighting schedule (lights on 07:00 hr, off 19:00 hr). Genotyping of ERa mutant and ERb mutant mice was undertaken as described previously (Abraham et al., 2003) . Adult (>60 days of age) wild-type and ER mutant female C57BL6/J mice were anesthetized with Halothane, ovariectomized, and implanted subcutaneously with an estradiol-filled Silastic capsule. Estradiol capsules were made according to the protocol of Bronson (Bronson, 1981) , and involved filling Silastic tubing (1.0 mm internal, 2.1 mm external diameter; Dow Corning, MI) with Silastic medical-grade adhesive (Dow Corning) containing 17-bestradiol at a concentration of 0.1 mg/ml adhesive. Each mouse was given an w1 cm length of Silastic tubing (1 mg estradiol/20 g body weight). To prevent infection in brain-specific ERa knockout mice (see below), ERa fl/fl ;CamKIIa-Cre mice and controls were given daily s.c. injections of 5 ml/g Baytril 0.1% (Bayer, Leverkusen, Germany) for 5 consecutive days, starting 2 days pre-ovariectomy (OVX). Six days after OVX, mice received a subcutaneous injection of estradiol benzoate (1 mg/20g body weight, Intervet, Castle Hill, Australia) at 09:00 hr. On the following day, animals were killed with an i.p. overdose of pentobarbitone, and trunk blood was collected between 17:00 and 21:00 hr for LH radioimmunoassay. The sensitivity of the radioimmunoassay was 0.4 ng/ml and had an intra-assay coefficient of variation of 12.1%.
Five separate LH surge experiments were undertaken. In the first, wild-type mice were treated as above and groups of 4-5 mice were killed at 17:00 hr, 18:00 hr, 19:00 hr, 20:00 hr, and 21:00 hr to ascertain the profile of the LH surge. As this showed that 19:00 hr represented the time of peak LH secretion, further experiments were undertaken by killing mice at 19:00 hr. In the second experiment, ERa mutant and wild-type littermates (n = 7-8 each group) were treated as above and anesthetized with pentobarbitone. A 0.3 ml blood sample was obtained from the right atrium before perfusion of the mouse through the left ventricle with 15 ml 4% paraformaldehyde fixative solution. Brains were then removed and postfixed for 90 min at room temperature in 4% paraformaldehyde before being placed in a 30% sucrose/Tris-buffered saline (TBS) solution overnight. The third experiment involved the same procedure, only using ERb mutant mice and wild-type littermates (n = 7 each group). The fourth experiment used wild-type adult female mice given the estrogenreplacement protocol, only with half of the mice receiving the ERaselective agonist 16a-LE2 (0.8 mg/20 g body weight, s.c.; kind gift of Schering AG, Berlin, Germany) instead of the estradiol benzoate injection. At this dose, 16a-LE2 is highly selective for ERa in vivo , and ERa +/fl genotypes) treated as above. To evaluate possible altered timing of positive feedback and the LH surge in these mice, animals were perfused at 13:00 hr, 19:00 hr, and 01:00 hr with pituitaries additionally collected alongside the brains. In each experiment, individual control and ER mutant mice were perfused in an alternate manner.
Immunohistochemistry
Single-label ERa immunohistochemistry was performed using either the monoclonal rat H222 antibody (1.3 mg/ml, gift of Abbott Laboratories, IL) for free-floating brain sections or a polyclonal rabbit antibody (1 mg/ml, MC-20, SC-542, Santa Cruz Biotechnology, CA) for the pituitary. Brain sections were cut in the coronal plane at 30 mm on a freezing microtome and processed as free-floating sections using biotinylated anti-rat IgGs followed by the VECTASTAIN ABC system (Vector Laboratories) with nickel-diaminobenzidine as the chromagen. Fixed pituitaries were dehydrated, embedded in paraffin wax, and cut into 6 mm sections for slide-mounted immunohistochemistry using biotinylated anti-rabbit IgGs and the VECTASTAIN ABC system with diaminobenzidine.
Dual-label c-Fos and GnRH immunocytochemistry was undertaken as described previously (Herbison et al., 1995) . Briefly, the rostral forebrain was cut into three sets of 30 mm-thick coronal sections and one set was immunostained for c-Fos (Li et al., 1999 ) using a polyclonal rabbit anti-c-Fos antibody (1:10,000, SC52, Santa Cruz Biotechnology Inc., Santa Cruz, CA) followed by biotinylated anti-rabbit IgGs (1:200; Vector, Burlingame, CA) and Vector Elite avidin-peroxidase (1:100) and revealed using nickel-diaminobenzedine hydrochloride. A second sequential staining using a rabbit anti-GnRH antibody (1:40,000; LR1, gift of R. Benoit, Montreal) and peroxidase-labeled anti-rabbit immunoglobulins (1:400; Vector Labs) revealed by diaminobenzidine hydrochloride alone was used to visualize the GnRH neurons. The removal of either primary antibodies resulted in a complete absence of the respective immunoreactivity.
Analysis was undertaken by counting the numbers of single-labeled (brown cytoplasm only) and dual-labeled (brown cytoplasm and black nucleus) GnRH neurons. The distribution and number of dual-labeled GnRH neurons were counted in the regions of the medial septum, rostral preoptic area, and anterior hypothalamic area, represented by plates 22-24, 25-27, and 28-31, respectively, of the Franklin and Paxinos brain atlas (Franklin and Paxinos, 1997) . In addition, the number of c-Fos-labeled cells identified within the AVPV, PeN, and MePN were counted. Cell counts in the AVPV were determined by placing a right-angle triangle (160 mm base 3 400 mm side) over the AVPV (plate 29) and counting all immunoreactive nuclei bilaterally on two sections from each mouse. The same procedure was undertaken for the MnPO by placing a square (300 mm 3 300 mm) over the midline MnPO (plate 27) and counting the numbers of c-Fos-immunoreactive cells in 2 sections from each mouse. Counts in the PeN were undertaken in the same way by placing a rectangle (60 mm 3 800 mm) next to the third ventricle and the level of plate 31. Values for each mouse were used to determine mean counts and these were used to generate means + SEM values for each group. All data were analyzed by nonparametric Mann-Whitney U tests with a p < 0.05 considered significant.
Conditional Pseudorabies Virus Tracing
The conditional PRV strain, Ba2001, was generated as described previously (DeFalco et al., 2001 ) (3.8 3 10 8 pfu/ml) and stored at 280 C until use. Intracerebral stereotaxic injections of Ba2001 were made in Avertin-anaesthetized adult female GnRH-Cre mice. A Hamilton syringe was used to deliver 500 nl of Ba2001 into the rostral preoptic area (coordinates: 0.0 mm bregma, 0 mm lateral, 25.1 mm dorsal-ventral) at a rate of 20 nl/min. The needle was left in place for 5 min following injection. Control injections were made into the preoptic area of wild-type mice and into the striatum of GnRH-Cre mice. Mice were killed at various time points after injection and brain tissue was prepared for immunohistochemical processing as described above. Thirty-micrometer-thick sections underwent dual labeling for either GFP (to detect PRV infected cells) and GnRH or GFP and ERa. The following antibodies were used: chicken anti-GFP (1:2500; Chemicon), rabbit anti-GFP (1:5000, Molecular Probes), rabbit anti-GnRH antibody (1:40,000; LR1, gift of R. Benoit, Montreal), and rabbit anti-ERa (1:10,000, Upstate). GFP/GnRH dual labeling was visualized using anti-rabbit IgGs followed by streptavidin 568 (1:200; Molecular Probes) and anti-chicken FITC (1:200; Jackson Immunolabs). GFP/ERa dual labeling was visualized with biotinylated anti-rabbit IgGs followed by streptavidin 568 (1:200; Molecular Probes), and anti-chicken FITC (1:200; Jackson Immunolabs). Every section throughout the brain of 72 hr post-injection female mice (n = 6) was analyzed for GFP/GnRH dual labeling using an Olympus BX51 epifluorescence microscope. Dual labeling for GFP/ERa was analyzed in every third section throughout the forebrain (n = 5). GFP/ ERa/Nissl staining was undertaken by including a final incubation step in Neurotrace 435/455 blue fluorescent Nissl stain (1:100, Molecular Probes).
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/52/2/271/DC1/.
